Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Polymorphism of CYP2D6 in Black populations: implications for psychopharmacology
Home
Publications
Polymorphism of CYP2D6 in Black populations: implications for psychopharmacology
Polymorphism of CYP2D6 in Black populations: implications for psychopharmacology
Authors:
LB
L. DiAnne Bradford
L. DiAnne Bradford
WK
Ward G. Kirlin
Ward G. Kirlin
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Download PDF
Download
Open Access
Publisher website
Google Scholar
1 December 1998
journal article
Published by
Oxford University Press (OUP)
in
International Journal of Neuropsychopharmacology
Vol. 1
(2)
,
173-185
DOI:
10.1017/s1461145798001187
PMID:
11281961
Abstract
Drug-metabolizing enzymes found primarily in the liver (CYP450) are a major determinant of therapeutic drug response. Polymorphism dependent upon race
Keywords
BLACK POPULATIONS
PSYCHOPHARMACOLOGY DRUG-METABOLIZING
DRUG-METABOLIZING ENZYMES
DRUG RESPONSE
ENZYMES FOUND
FOUND PRIMARILY
MAJOR DETERMINANT
THERAPEUTIC DRUG
BLACK
DRUG-METABOLIZING
Related articles
Cited
Cited by 32 articles
Scroll to top